Breast lumps other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{{CMG}} {{AE}} {{S.M}} | {{CMG}} {{AE}} {{S.M}} | ||
==Overview== | ==Overview== | ||
The only certain method to approve the presence of breast malignancy is [[breast lump]] [[biopsy]].The three types of biopsy are core-needle biopsy, open surgical biopsy, and fine needle biopsy. | |||
== Other Diagnostic Studies== | == Other Diagnostic Studies== | ||
===[[Biopsy]]:=== | ===[[Biopsy]]:=== | ||
The only certain method to approve the presence of breast malignancy is [[breast lump]] [[biopsy]] <ref name=":0">John M. Eisenberg Center for Clinical Decisions and Communications Science. Having a Breast Biopsy: A Review of the Research for Women and Their Families. 2016 May 26. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368364/ </ref> | The only certain method to approve the presence of breast malignancy is [[breast lump]] [[biopsy|biopsy.]]<ref name=":0">John M. Eisenberg Center for Clinical Decisions and Communications Science. Having a Breast Biopsy: A Review of the Research for Women and Their Families. 2016 May 26. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368364/ </ref> | ||
There are three types of biopsy: | There are three types of biopsy: | ||
* | *Core-needle biopsy | ||
* | *Open surgical biopsy | ||
* | *Fine needle biopsy<ref name=":1">Casaubon JT, Regan JP. Breast Masses, Fine Needle Aspiration. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470268/</ref> | ||
Core-needle biopsy<ref name=":0" /> | '''Core-needle biopsy:'''<ref name=":0" /> | ||
*Ultrasound guided-core needle biopsy<ref name="pmid11698631">{{cite journal| author=Yeow KM, Lo YF, Wang CS, Chang HK, Tsai CS, Hsueh C| title=Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses. | journal=J Vasc Interv Radiol | year= 2001 | volume= 12 | issue= 11 | pages= 1313-7 | pmid=11698631 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11698631 }} </ref> | *[[Ultrasound]] guided-core needle biopsy:<ref name="pmid11698631">{{cite journal| author=Yeow KM, Lo YF, Wang CS, Chang HK, Tsai CS, Hsueh C| title=Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses. | journal=J Vasc Interv Radiol | year= 2001 | volume= 12 | issue= 11 | pages= 1313-7 | pmid=11698631 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11698631 }} </ref> | ||
**The needle is guided by use of ultrasound and patient lies on back or side | **The needle is guided by use of [[ultrasound]] and patient lies on back or side | ||
** Highly sensitivity and specificity | ** Highly [[sensitivity]] and [[specificity]] | ||
**Choice method for breast tissue sampling | **Choice method for breast tissue sampling | ||
*Stereotactic-guided core-needle biopsy | *Stereotactic-guided core-needle biopsy | ||
**The needle is guided by use of x-ray and computer and patient lie on stomach | **The needle is guided by use of [[x-ray]] and computer and patient lie on [[stomach]] | ||
**Choice method for mammograohically suspicious breast lumps which are occult in ultrasound<ref name="pmid20074953">{{cite journal| author=Ward ST, Shepherd JA, Khalil H| title=Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinic. | journal=Breast | year= 2010 | volume= 19 | issue= 2 | pages= 105-8 | pmid=20074953 | doi=10.1016/j.breast.2009.12.003 | pmc= | url=htps://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20074953 }} </ref> | **Choice method for mammograohically suspicious [[breast lumps]] which are occult in [[ultrasound]]<ref name="pmid20074953">{{cite journal| author=Ward ST, Shepherd JA, Khalil H| title=Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinic. | journal=Breast | year= 2010 | volume= 19 | issue= 2 | pages= 105-8 | pmid=20074953 | doi=10.1016/j.breast.2009.12.003 | pmc= | url=htps://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20074953 }} </ref> | ||
*MRI-guided core-needle biopsy | *MRI-guided core-needle biopsy | ||
**The needle is guided by Magnetic resonance imaging | **The needle is guided by [[Magnetic resonance imaging]] | ||
*Freehand core-needle biopsy | *Freehand core-needle biopsy | ||
**Usually used for breast lumps which can be felt by hand on breast tissue | **Usually used for [[breast lumps]] which can be felt by hand on breast tissue | ||
Core-needle biopsy has lower risk of complications such as bleeding, bruising and infection | Core-needle biopsy has lower risk of [[complications]] such as [[bleeding]], [[bruising]] and [[infection]] | ||
Open surgical biopsy<ref name=":0" /> | '''Open surgical biopsy:'''<ref name=":0" /> | ||
*Perform under general anesthesia | *Perform under [[general anesthesia]] | ||
*If core-needle biopsy is unavailable due to location of breast lump, open surgical biopsy is required | *If core-needle biopsy is unavailable due to location of breast lump, open surgical biopsy is required | ||
*In patients with high risk of cancer is recommended | *In patients with high risk of [[cancer]] is recommended | ||
*1-2 inch cut on breast tissue for breast lump removal | *1-2 inch cut on breast tissue for breast lump removal | ||
*Higher risk of complications (bruising, bleeding, pain and infection) | *Higher risk of [[complications]] ([[bruising]], [[bleeding]], [[pain]] and [[infection]]) | ||
Fine needle biopsy (FNA)<ref name=":1" /> | Fine needle biopsy ([[FNA]]):<ref name=":1" /> | ||
*Performed by small needle (21-25 gauge) | *Performed by small needle (21-25 gauge) | ||
*Regarding to small amount of breast tissue, FNA is considered as controversial method for breast lump diagnosis | *Regarding to small amount of breast tissue, [[FNA]] is considered as controversial method for breast lump diagnosis | ||
*Performed for large and symptomatic breast cysts or imaginary abnormalities | *Performed for large and symptomatic breast [[cysts]] or imaginary abnormalities | ||
*Complications of FNA include bruising, bleeding, pain, infection and pneumothorax;if needle goes deep inside the chest) | *Complications of [[FNA]] include [[bruising]], [[bleeding]], [[pain]], [[infection]] and [[pneumothorax]]; if needle goes deep inside the chest) | ||
*Due to inadequate tissue or nondiagnostic results, FNA has lower rate of diagnosis rather than core-needle biopsy | *Due to inadequate tissue or nondiagnostic results, [[FNA]] has lower rate of diagnosis rather than core-needle biopsy | ||
*FNA advantages | *[[FNA]] advantages | ||
**Cost-effectiveness | **[[Cost-effectiveness]] | ||
**Less invasive method | **Less [[invasive]] method | ||
**Suitable for patient under anticoagulant therapy | **Suitable for patient under [[anticoagulant therapy]] | ||
**Appropriate to sample axillary tissue | **Appropriate to sample axillary tissue | ||
*FNA follow-up | *[[FNA]] follow-up: | ||
**Non-bloody fluid/resolved cyst | **Non-bloody fluid/resolved [[cyst]] | ||
*** Ultrasound follow-up to reassure the cyst has been resolved | *** [[Ultrasound]] follow-up to reassure the [[cyst]] has been resolved | ||
***No more follow-up | ***No more follow-up | ||
**Bloody fluid/ persistent cyst | **Bloody fluid/ persistent [[cyst]] | ||
***Refer to a surgeon for open surgical biopsy | ***Refer to a surgeon for open surgical [[biopsy]] | ||
Triple test score is used by surgeons for assessment of palpable breast lumps <ref>Morris KT, Pommier RF, Morris A, et al. Usefulness of the Triple Test Score for Palpable Breast Masses. Arch Surg. 2001;136(9):1008–1013. doi:10.1001/archsurg.136.9.1008</ref> <ref name="pmid23104707">{{cite journal| author=Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y et al.| title=A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. | journal=Ann Surg Oncol | year= 2013 | volume= 20 | issue= 3 | pages= 850-5 | pmid=23104707 | doi=10.1245/s10434-012-2710-y | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23104707 }} </ref> | [[Triple test]] score is used by surgeons for assessment of palpable [[breast lumps]]:<ref>Morris KT, Pommier RF, Morris A, et al. Usefulness of the Triple Test Score for Palpable Breast Masses. Arch Surg. 2001;136(9):1008–1013. doi:10.1001/archsurg.136.9.1008</ref><ref name="pmid23104707">{{cite journal| author=Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y et al.| title=A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy. | journal=Ann Surg Oncol | year= 2013 | volume= 20 | issue= 3 | pages= 850-5 | pmid=23104707 | doi=10.1245/s10434-012-2710-y | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23104707 }} </ref> | ||
*Classic triple test: | *Classic [[triple test]]: | ||
**Clinical breast examination, FNA and mammography | **Clinical breast examination, [[FNA]] and [[mammography]] | ||
*Modified version of triple test | *Modified version of [[triple test]] | ||
**Clinical breast examination, Core-needle biopsy and ultrasound | **Clinical breast examination, Core-needle biopsy and [[ultrasound]] | ||
*Palpation, mammography and biopsy are required for women aged > 35 years <ref>Santen RJ. Benign Breast Disease in Women. [Updated 2018 May 25]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278994/</ref> | *[[Palpation]], [[mammography]] and [[biopsy]] are required for women aged > 35 years <ref>Santen RJ. Benign Breast Disease in Women. [Updated 2018 May 25]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278994/</ref> | ||
**If mammography is negative, biopsy is needed to rule out malignancy especially lobular carcinoma | **If [[mammography]] is negative, [[biopsy]] is needed to rule out [[malignancy]] especially [[Lobular carcinoma in situ|lobular carcinoma]] | ||
*Palpation, ultrasound and biopsy are suggested for women <35 years | *[[Palpation]], [[ultrasound]] and [[biopsy]] are suggested for women <35 years | ||
**Surgeons may omit biopsy for fibroadenoma features on ultrasound and prefer 6 month follow-up for 2 years | **Surgeons may omit [[biopsy]] for [[fibroadenoma]] features on [[ultrasound]] and prefer 6 month follow-up for 2 years | ||
**Some surgeons recommend core-needle biopsy or FNA for all fibroadenomas | **Some surgeons recommend core-needle biopsy or [[FNA]] for all [[fibroadenomas]] | ||
***Particularly in carriers of BRCA mutation | ***Particularly in carriers of [[BRCA]] [[mutation]] | ||
*** Reduce the need for serial ultrasound | *** Reduce the need for serial [[ultrasound]] | ||
==References== | ==References== |
Revision as of 16:19, 4 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps other diagnostic studies On the Web |
American Roentgen Ray Society Images of Breast lumps other diagnostic studies |
Risk calculators and risk factors for Breast lumps other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
The only certain method to approve the presence of breast malignancy is breast lump biopsy.The three types of biopsy are core-needle biopsy, open surgical biopsy, and fine needle biopsy.
Other Diagnostic Studies
Biopsy:
The only certain method to approve the presence of breast malignancy is breast lump biopsy.[1]
There are three types of biopsy:
- Core-needle biopsy
- Open surgical biopsy
- Fine needle biopsy[2]
Core-needle biopsy:[1]
- Ultrasound guided-core needle biopsy:[3]
- The needle is guided by use of ultrasound and patient lies on back or side
- Highly sensitivity and specificity
- Choice method for breast tissue sampling
- Stereotactic-guided core-needle biopsy
- The needle is guided by use of x-ray and computer and patient lie on stomach
- Choice method for mammograohically suspicious breast lumps which are occult in ultrasound[4]
- MRI-guided core-needle biopsy
- The needle is guided by Magnetic resonance imaging
- Freehand core-needle biopsy
- Usually used for breast lumps which can be felt by hand on breast tissue
Core-needle biopsy has lower risk of complications such as bleeding, bruising and infection
Open surgical biopsy:[1]
- Perform under general anesthesia
- If core-needle biopsy is unavailable due to location of breast lump, open surgical biopsy is required
- In patients with high risk of cancer is recommended
- 1-2 inch cut on breast tissue for breast lump removal
- Higher risk of complications (bruising, bleeding, pain and infection)
- Performed by small needle (21-25 gauge)
- Regarding to small amount of breast tissue, FNA is considered as controversial method for breast lump diagnosis
- Performed for large and symptomatic breast cysts or imaginary abnormalities
- Complications of FNA include bruising, bleeding, pain, infection and pneumothorax; if needle goes deep inside the chest)
- Due to inadequate tissue or nondiagnostic results, FNA has lower rate of diagnosis rather than core-needle biopsy
- FNA advantages
- Cost-effectiveness
- Less invasive method
- Suitable for patient under anticoagulant therapy
- Appropriate to sample axillary tissue
- FNA follow-up:
- Non-bloody fluid/resolved cyst
- Ultrasound follow-up to reassure the cyst has been resolved
- No more follow-up
- Bloody fluid/ persistent cyst
- Refer to a surgeon for open surgical biopsy
- Non-bloody fluid/resolved cyst
Triple test score is used by surgeons for assessment of palpable breast lumps:[5][6]
- Classic triple test:
- Clinical breast examination, FNA and mammography
- Modified version of triple test
- Clinical breast examination, Core-needle biopsy and ultrasound
- Palpation, mammography and biopsy are required for women aged > 35 years [7]
- If mammography is negative, biopsy is needed to rule out malignancy especially lobular carcinoma
- Palpation, ultrasound and biopsy are suggested for women <35 years
- Surgeons may omit biopsy for fibroadenoma features on ultrasound and prefer 6 month follow-up for 2 years
- Some surgeons recommend core-needle biopsy or FNA for all fibroadenomas
- Particularly in carriers of BRCA mutation
- Reduce the need for serial ultrasound
References
- ↑ 1.0 1.1 1.2 John M. Eisenberg Center for Clinical Decisions and Communications Science. Having a Breast Biopsy: A Review of the Research for Women and Their Families. 2016 May 26. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK368364/
- ↑ 2.0 2.1 Casaubon JT, Regan JP. Breast Masses, Fine Needle Aspiration. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470268/
- ↑ Yeow KM, Lo YF, Wang CS, Chang HK, Tsai CS, Hsueh C (2001). "Ultrasound-guided core needle biopsy as an initial diagnostic test for palpable breast masses". J Vasc Interv Radiol. 12 (11): 1313–7. PMID 11698631.
- ↑ Ward ST, Shepherd JA, Khalil H (2010). [htps://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20074953 "Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinic"]. Breast. 19 (2): 105–8. doi:10.1016/j.breast.2009.12.003. PMID 20074953.
- ↑ Morris KT, Pommier RF, Morris A, et al. Usefulness of the Triple Test Score for Palpable Breast Masses. Arch Surg. 2001;136(9):1008–1013. doi:10.1001/archsurg.136.9.1008
- ↑ Wai CJ, Al-Mubarak G, Homer MJ, Goldkamp A, Samenfeld-Specht M, Lee Y; et al. (2013). "A modified triple test for palpable breast masses: the value of ultrasound and core needle biopsy". Ann Surg Oncol. 20 (3): 850–5. doi:10.1245/s10434-012-2710-y. PMID 23104707.
- ↑ Santen RJ. Benign Breast Disease in Women. [Updated 2018 May 25]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278994/